Finafloxacin — Active Pharmaceutical Ingredient

Finafloxacin is an active pharmaceutical ingredient found in 1 FDA-approved drug product. Forms: SUSPENSION/DROPS. Routes: OTIC.

This content is for informational purposes only. Always consult a healthcare professional.

Finafloxacin (1 brand name, 1 dosage form, 1 route)

Available dosage forms: SUSPENSION/DROPS.

Routes of administration: OTIC.

Brand Names

  • XTORO

Indications and Usage

XTORO® is indicated for the treatment of acute otitis externa (AOE) with or without an otowick, caused by susceptible strains of Pseudomonas aeruginosa and Staphylococcus aureus in patients age 1 year and older.

Dosage and Administration

Instill four drops into the affected ear(s) twice daily for seven days. For patients requiring use of an otowick, the initial dose can be doubled (to 8 drops), followed by 4 drops instilled into the affected ear twice daily for seven days. Important administration instructions include: Warm the suspension by holding the bottle in the hand for one or two minutes prior to dosing in order to avoid dizziness which may result from the instillation of a cold suspension. Shake bottle well before use. Lie with the affected ear upward, instill the drops, and maintain the position for 60 seconds to facilitate penetration of the drops into the ear canal. Repeat if necessary for the opposite ear.

Contraindications

None.

Warnings and Precautions

As with other antibacterial preparations, prolonged use of XTORO may lead to overgrowth of nonsusceptible organisms, including yeast and fungi. If this occurs, discontinue use and institute alternative therapy.

Mechanism of Action

Finafloxacin is a fluoroquinolone antimicrobial [see Microbiology (12.4)].

⚠ Caution
Medical Disclaimer: This information is for educational purposes only. Always consult a healthcare professional before taking any medication.